AdvisorShares Pure US Cannabis ETF (MSOS)

NYSEArca

4.69
+0.17 (+3.76%)
Updated Aug 19, 3:48 PM ET
AI Rating
Hold
Overall Score
57
Trend
32
Momentum
81
Risk
64

Scores are generated from technical indicators for educational purposes and are not a recommendation to buy or sell.

Price history

Daily closes and volume
Feb 24, 2026 120 sessions Aug 14, 2026

AI Analysis

AdvisorShares Pure US Cannabis ETF is trading at $4.69, up 3.76% on the session. The 50 day average sits at $4.64 and the 200 day at $n/a, which puts the stock in a mixed technical position. RSI is at 56, which reads as strong, and MACD is bullish crossover. Volume is below average.

The nearest support is around $4.44 with resistance near $4.78, so that band frames the current range. Average daily movement is roughly $0.22, or about 4.8% of the share price, which is what any stop placement has to allow for. The overall health score of 57 out of 100 combines a trend score of 32, momentum of 81 and a risk score of 64.

Technical indicators

RSI (14)
56.0
strong
MACD
0.005
bullish crossover
SMA 20
4.34
SMA 50
4.64
SMA 200
--
unknown
ATR (14)
0.22
avg daily range
Support
4.44
Resistance
4.78
Volume vs 20d
0.70x
below average
Volatility
52.1%
annualised
1 month
+6.19%
3 months
-4.34%

About AdvisorShares Pure US Cannabis ETF

The fund is an actively managed ETF that seeks to achieve its investment objective by investing, under normal circumstances, at least 80% of its net assets (plus any borrowings for investment purposes) in securities of companies that derive at least 50% of their net revenue from the marijuana and hemp business in the United States and in derivatives that have economic characteristics similar to such securities. It will concentrate at least 25% of its investments in the pharmaceuticals, biotechnology & life sciences industry group within the health care sector. The fund is non-diversified.

Stay Ahead of the Market

Get daily AI insights, market updates, and trade opportunities delivered to your inbox.